Delivery Order SPE2DB25D3504-SPE2DB25FVUGA

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,126, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a vaccine product, with a period of performance through December 27, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,836.00, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes and has a completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This federal contract award, valued at $4,128.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product, with a completion date of November 21, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a larger...
This federal contract award, valued at $10,415.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product, with an ultimate completion date of December 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,431.78, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product likely related to COVID-19 vaccination. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2025. This award is not designated as a set-aside...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,418.00 contract is for SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product, with a completion date of January 27, 2025. The award is not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,397.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML syringes, with an ultimate completion date of November 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned in the information provided. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,367.93 firm fixed-price delivery order is for SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, with a completion date of September 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,128.96 firm fixed-price delivery order is for the provision of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, with an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,431.78, is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of April 7, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUGA
    Delivery Order

This federal contract award, valued at $1,431.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, a medical product, with a completion date of May 5, 2025.

The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:58 AM